Production (Stage)
Milestone Pharmaceuticals Inc.
MIST
$1.73
-$0.01-0.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -37.46% | 5.59% | 0.89% | -4.95% | -11.36% |
| Total Receivables | -14.69% | 18.33% | -4.93% | 27.75% | -17.31% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -0.25% | -42.10% | -63.76% | -68.28% | -56.64% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 76.90% | -71.92% | -- | -- | -- |
| Total Current Assets | -35.64% | 1.22% | -4.49% | -7.62% | -13.40% |
|
|
|||||
| Total Current Assets | -35.64% | 1.22% | -4.49% | -7.62% | -13.40% |
| Net Property, Plant & Equipment | -30.68% | -28.30% | -26.00% | -23.64% | -20.92% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -35.54% | 0.36% | -5.06% | -8.03% | -13.57% |
|
|
|||||
| Total Accounts Payable | 38.04% | -51.47% | -12.08% | -68.75% | -39.40% |
| Total Accrued Expenses | 443.13% | 108.34% | -46.85% | -16.43% | -3.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.34% | 4.58% | 9.81% | 8.62% | 9.47% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 213.87% | 12.46% | -35.20% | -32.93% | -48.14% |
|
|
|||||
| Total Current Liabilities | 213.87% | 12.46% | -35.20% | -32.93% | -48.14% |
| Long-Term Debt | 7.19% | 7.19% | 7.19% | 7.19% | 7.02% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -41.96% | -40.01% | -36.70% | -33.14% | -29.86% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.27% | 6.67% | 0.14% | 1.14% | -1.86% |
|
|
|||||
| Common Stock & APIC | 1.82% | 11.31% | 11.51% | 12.22% | 12.71% |
| Retained Earnings | -15.44% | -12.73% | -13.69% | -16.28% | -19.58% |
| Treasury Stock & Other | 0.00% | 9.53% | 9.53% | 9.53% | 9.53% |
| Total Common Equity | -115.34% | -21.61% | -15.76% | -20.86% | -25.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -115.34% | -21.61% | -15.76% | -20.86% | -25.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -115.34% | -21.61% | -15.76% | -20.86% | -25.98% |
|
|
|||||